EPM Evolution delivers 782 percent Q1 2026 EPS surprise shares rise modestly on upbeat investor sentiment IKT Inhibikase Therapeutics beats Q4 2025 loss estimates shares post modest gains following earnings release HVMC Highview CEO lays out targeted strategic growth priorities to deliver longterm value for shareholders RCMT RCM Technologies posts 218 Q4 2025 EPS beat shares edge 103 higher on positive investor sentiment